Treatment Role of Terpenoid Fraction of Perovskia abrotanoides Kar. on Zoonotic Cutaneous Leishmaniasis in Animal Model
Abstract
Leishmaniasis is one of the infectious diseases in tropical countries that is seen as cutaneous, mucocutaneous and visceral forms. Due to the side effects, costs and effectiveness of anti-leishmaniasis drugs, many clinical trials have been conducted on the importance of plant-based substances against leishmaniasis. Therefore, the following study was performed to evaluate the therapeutic effects of Perovskia abrotanoides Kar. terpenoid fraction on cutaneous leishmaniasis in Balb/c mice. The ethanol: water (80:20) extract of the plant flowers was fractionated by Medium Pressure Liquid Chromatography using RP-18 column. The terpenoid-rich fraction was detected by TLC and HNMR analyses and evaluated for healing effects on cutaneous leishmaniasis in mice with concentrations of 0.8%, 1.6% and 3.2 µg/mL. The effect of that was evaluated using ANOVA statistical tests. The results indicate that terpenoid of P. abrotanoides in 3.2% concentration is effective in treating cutaneous leishmaniasis in mice and also increases the lifespan and decreases the parasite burden of infected mice. According to this result, it is suggested that the effectiveness of this extract on the treatment of cutaneous leishmaniasis to be evaluated as a clinical trial in humans.
Torres-Guerrero E, Quintanilla-Cedillo MR, Ruiz-Esmenjaud J, Arenas R. Leishmaniasis: a review. F1000Research 2017;6:1-15.
Gangneux J-P, Sauzet S, Donnard S, Meyer N, Cornillet A, et al. Recurrent american cutaneous leishmaniasis. Emerg Infect Dis 2007;13:1436-1438.
Alavi-Naini R. Topical morphine for the treatment of cutaneous leishmaniasis. Med Hypotheses 2008;70:81-84.
Ait-Oudhia K, Gazanion E, Oury B, Vergnes B, Sereno D. The fitness of antimony-resistant Leishmania parasites: lessons from the field. Trends in parasitol 2011;27:141-142.
Hefnawy A, Berg M, Dujardin J-C, De Muylder G. Exploiting knowledge on leishmania drug resistance to support the quest for new drugs. Trends in parasitol 2017;33:162-174.
Zadeh Mehrizi T, Pirali Hamedani M, Ebrahimi Shahmabadi H, Mirzaei M, Shafiee Ardestani M, et al. Effective materials of medicinal plants for leishmania treatment in vivo environment. J Med Plants 2020;19:39-62.
Sajjadi SE, Mehregan I, Khatamsaz M, Asgari G. Chemical composition of the essential oil of Perovskia abrotanoides Karel. growing wild in Iran. Flavour Fragr J 2005;20:445-446.
Mahboubi M, Kazempour N. The antimicrobial activity of essential oil from Perovskia abrotanoides karel and its main components. Indian J Pharm Sci 2009;71:343-347.
Sairafianpour M, Christensen J, Bogdan AB, Kharazmi A, Bagherzadeh K, et al. Leishmanicidal, antiplasmodial, and cytotoxic activity of novel diterpenoid 1,2-Quinones from Perovskia abrotanoides: new source of tanshinones. J Nat Prod 2001;64:1398-1403.
Soosaraei M, Fakhar M, Hosseini Teshnizi S, Ziaei Hezarjaribi H, Sadat Banimostafavi ES. Medicinal plants with promising antileishmanial activity in Iran: a systematic review and meta-analysis. Ann Med Surg 2017;21:63-80.
Hafez Ghoran S, Azadi B, Hussain H. Chemical composition and antimicrobial activities of Perovskia artemisioides Boiss. essential oil. Nat Prod Res 2016;30:1997-2001.
Hejazi S, Macvandi S, Abedi S, Soleimanifard S. The study of the inhibitory effects of aqueous and ethanolic extracts of Ziziphora tenuior L. on the proliferation of leishmania major amastigotes. Iranian J of Dermatol 2018;21:71-76.
Azwanida N. A review on the extraction methods use in medicinal plants, principle, strength and limitation. Med Aromat Plants 2015;4:1000196.
Soleimanifard S, Arjmand R, Saberi S, Salehi M, Hejazi SH. Treatment outcome of the drug-resistant zoonotic cutaneous leishmaniasis by glucantime. Adv Biomed Res 2017;6:17.
Nilforoushzadeh MA, Jaffary F, Derakhshan R, Haftbaradaran E. Comparison between intralesional meglumine antimoniate and combination of trichloroacetic acid 50% and intralesional meglumine antimoniate in the treatment of acute cutaneous leishmaniasis: a randomized clinical trial. J Skin Stem Cell 2014;1:e16633.
Nilforoushzadeh MA, Sadeghian G, Jaffary F, Ziaei H, Shirani-Bidabad L, et al. Successful treatment of lupoid cutaneous leishmaniasis with glucantime and topical trichloroacetic acid (a case report). Korean J Parasitol 2008;46:175-177.
Shanmugam S, Manikandan K, Rajendran K. Ethnomedicinal survey of medicinal plants used for the treatment of diabetes and jaundice among the villagers of sivagangai district tamilnadu. Ethnobot Leafl 2009;13:189-194.
Tabefam M. Farimani MM, Danton O, Ramseyer J, Kaiser M, et al. Antiprotozoal diterpenes from Perovskia abrotanoides. Planta Med 2018;84:913-919.
Beikmohammadi M. The evaluation of medicinal properties of Perovskia abrotanoides Karel
Middle East J Sci Res 2012;11:189-193.
Belachew TF, Asrade S, Geta M, Engidaw F. In vivo evaluation of wound healing and anti-inflammatory activity of 80% methanol crude flower extract of hagenia abyssinica (Bruce) J.F. Gmel in Mice. Evid Based Complement Alternat Med 2020;9645792.
Jaafari MR, Hooshmand S, Samiei A, Hossainzadeh H. Evaluation of-leishmanicidal effect of Perovskia abrotanoides Karel root extract by in vitro leishmanicidal assay using promastigotes of Leishmania major. Pharmacol Online 2007;1:299-303.
Kayser O, Kiderlen A, Croft S. Natural products as antiparasitic drugs. Parasitol Res 2003;90:S55-S62.
Obame L, Edou P, Bassole I, Koudou J, Agnaniet H, et al. Chemical composition, antioxidant and antimicrobial properties of the essential oil of Dacryodes edulis (G. Don) HJ Lam from Gabon. African J of Microbiol Res 2008;2:148-152.
Vardar-Ünlü G, Candan F, Sökmen A, Daferera D, Polissiou M, et al. Antimicrobial and antioxidant activity of the essential oil and methanol extracts of thymus pectinatus Fisch. et Mey. Var. pectinatus (Lamiaceae). J Agric Food Chem 2003;51:63-67.
| Files | ||
| Issue | Vol 7, No 1, 2022 | |
| Section | Research Article(s) | |
| DOI | https://doi.org/10.18502/tim.v7i1.9064 | |
| Keywords | ||
| Cutaneous leishmaniasis Perovskia abrotanoides Kar Treatment Parasite load | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
